ClinicalTrials.Veeva

Menu

Inspiratory Muscle Training in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

G

Gazi University

Status

Completed

Conditions

Allogeneic Hematopoietic Stem Cell Transplantation

Treatments

Device: Inspiratory muscle training
Device: Sham inspiratory muscle training

Study type

Interventional

Funder types

Other

Identifiers

NCT02270346
GaziUniversity

Details and patient eligibility

About

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) causes various toxic effects in many body tissues, organs and systems such as immune, cardiovascular, pulmonary, gastrointestinal, neuroendocrine and musculoskeletal systems, liver, kidneys and skin.Available limited numbers of studies showed that inspiratory muscle weakness in allo-HSCT candidates and recipients. Although meta-analysis, systematic reviews and studies demonstrated beneficial effects of inspiratory muscle training on several outcomes in different disease groups; chronic obstructive pulmonary disease, bronchiectasis and heart failure, no published paper reported the effects of IMT in allo-HSC recipients.

Full description

Thirty-eight allo-HSCT recipients (˃100 days past post-transplant status) were included. Before and after 6-week IMT, maximal and submaximal exercise capacity, respiratory and peripheral muscle strength, pulmonary functions, dyspnea and fatigue perception, depression and quality of life were evaluated. Primary outcome measurement was respiratory muscle strength, secondary outcomes were exercise capacity, dyspnea, peripheral muscle strength, quality of life, fatigue and depression.

Enrollment

40 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Allo-HSC recipients (˃100 days past post-transplant status),
  • 18-65 years of age,
  • Under standard medications

Exclusion criteria

  • Having cognitive disorder, orthopedic problem or neurological disease that were affecting functional capacity,
  • Additional heart and lung diseases such as asthma, chronic obstructive pulmonary disease, acute infections or pneumonia,
  • Problems prevented performing assessment and training such as visual problems and mucositis

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups

Treatment group
Active Comparator group
Description:
Intervention: Treatment group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device.
Treatment:
Device: Inspiratory muscle training
Control group
Sham Comparator group
Description:
Sham: Control group received sham inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device .
Treatment:
Device: Sham inspiratory muscle training

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems